Page last updated: 2024-11-08

serine and Amentia

serine has been researched along with Amentia in 21 studies

Serine: A non-essential amino acid occurring in natural form as the L-isomer. It is synthesized from GLYCINE or THREONINE. It is involved in the biosynthesis of PURINES; PYRIMIDINES; and other amino acids.
serine : An alpha-amino acid that is alanine substituted at position 3 by a hydroxy group.

Research Excerpts

ExcerptRelevanceReference
"Frontotemporal dementia with parkinsonism linked to chromosome 17q21-22 (FTDP-17) is an autosomal dominant tauopathy manifested by a variable combination of personality changes, cognitive decline and hypokinetic-rigid movement disorder."1.32Frontotemporal dementia and parkinsonism with the P301S tau gene mutation in a Jewish family. ( Abramsky, O; Biran, I; Boher, M; Ekstein, D; Gal, A; Gomori, JM; Lossos, A; Meiner, Z; Newman, JP; Reches, A; Rosenmann, H; Soffer, D, 2003)

Research

Studies (21)

TimeframeStudies, this research(%)All Research%
pre-19901 (4.76)18.7374
1990's2 (9.52)18.2507
2000's16 (76.19)29.6817
2010's2 (9.52)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ashby, EL1
Miners, JS1
Kumar, S1
Walter, J1
Love, S1
Kehoe, PG1
Biemans, EA1
Verhoeven-Duif, NM1
Gerrits, J1
Claassen, JA1
Kuiperij, HB1
Verbeek, MM1
Inukai, Y1
Nonaka, T2
Arai, T2
Yoshida, M1
Hashizume, Y1
Beach, TG1
Buratti, E1
Baralle, FE1
Akiyama, H2
Hisanaga, S1
Hasegawa, M2
Nesgaard, L1
Vad, B1
Christiansen, G1
Otzen, D1
Kametani, F1
Suzuki, T1
Dohmae, N1
Lossos, A1
Reches, A1
Gal, A1
Newman, JP1
Soffer, D1
Gomori, JM1
Boher, M1
Ekstein, D1
Biran, I1
Meiner, Z1
Abramsky, O1
Rosenmann, H1
Kobayashi, K2
Kidani, T2
Ujike, H2
Hayashi, M2
Ishihara, T2
Miyazu, K1
Kuroda, S2
Koshino, Y2
Iijima, M1
Nakano, H1
Sugimori, K1
Shimazaki, M1
Alonso, Adel C1
Mederlyova, A1
Novak, M1
Grundke-Iqbal, I1
Iqbal, K1
Belorgey, D1
Sharp, LK1
Crowther, DC1
Onda, M1
Johansson, J1
Lomas, DA2
Pérez, M2
Ribe, E1
Rubio, A1
Lim, F2
Morán, MA1
Ramos, PG1
Ferrer, I1
Isla, MT1
Avila, J2
Saunders-Pullman, R1
Lipton, RB1
Senthil, G1
Katz, M1
Costan-Toth, C1
Derby, C1
Bressman, S1
Verghese, J1
Ozelius, LJ1
Dächsel, JC1
Ross, OA1
Mata, IF1
Kachergus, J1
Toft, M1
Cannon, A1
Baker, M1
Adamson, J1
Hutton, M1
Dickson, DW1
Farrer, MJ1
Spina, S1
Murrell, JR1
Yoshida, H1
Ghetti, B1
Bermingham, N1
Sweeney, B1
Dlouhy, SR1
Crowther, RA1
Goedert, M1
Keohane, C1
van Swieten, JC1
Bronner, IF1
Azmani, A1
Severijnen, LA1
Kamphorst, W1
Ravid, R1
Rizzu, P1
Willemsen, R1
Heutink, P1
Gaig, C1
Ezquerra, M1
Martí, MJ1
Valldeoriola, F1
Muñoz, E1
Lladó, A1
Rey, MJ1
Cardozo, A1
Molinuevo, JL1
Tolosa, E1
Van Deerlin, VM1
Leverenz, JB1
Bekris, LM1
Bird, TD1
Yuan, W1
Elman, LB1
Clay, D1
Wood, EM1
Chen-Plotkin, AS1
Martinez-Lage, M1
Steinbart, E1
McCluskey, L1
Grossman, M1
Neumann, M1
Wu, IL1
Yang, WS1
Kalb, R1
Galasko, DR1
Montine, TJ1
Trojanowski, JQ2
Lee, VM2
Schellenberg, GD1
Yu, CE1
Mawal-Dewan, M1
Schmidt, ML1
Balin, B1
Perl, DP1
Davis, RL1
Shrimpton, AE1
Holohan, PD1
Bradshaw, C1
Feiglin, D1
Collins, GH1
Sonderegger, P1
Kinter, J1
Becker, LM1
Lacbawan, F1
Krasnewich, D1
Muenke, M1
Lawrence, DA1
Yerby, MS1
Shaw, CM1
Gooptu, B1
Elliott, PR1
Finch, JT1
Carrell, RW1
Arrasate, M1
Komiya, T1
Narabayashi, H1
Kondo, T1

Clinical Trials (2)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Genetic Disease Gene Identification[NCT00916903]200 participants (Anticipated)Observational2005-10-31Enrolling by invitation
Clinical, Molecular and Biochemical Characterization of Familial Encephalopathy With Neuroserpin Inclusion Bodies[NCT00006176]100 participants Observational2000-08-10Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

21 other studies available for serine and Amentia

ArticleYear
Investigation of Aβ phosphorylated at serine 8 (pAβ) in Alzheimer's disease, dementia with Lewy bodies and vascular dementia.
    Neuropathology and applied neurobiology, 2015, Volume: 41, Issue:4

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Apolipoproteins E; Dementia; Deme

2015
CSF d-serine concentrations are similar in Alzheimer's disease, other dementias, and elderly controls.
    Neurobiology of aging, 2016, Volume: 42

    Topics: Aged; Aged, 80 and over; Aging; Alzheimer Disease; Biomarkers; Chromatography, High Pressure Liquid;

2016
Abnormal phosphorylation of Ser409/410 of TDP-43 in FTLD-U and ALS.
    FEBS letters, 2008, Aug-20, Volume: 582, Issue:19

    Topics: Amyotrophic Lateral Sclerosis; Animals; Antibodies, Monoclonal; Brain; Dementia; DNA-Binding Protein

2008
Kinetic partitioning between aggregation and vesicle permeabilization by modified ADan.
    Biochimica et biophysica acta, 2009, Volume: 1794, Issue:1

    Topics: Adaptor Proteins, Signal Transducing; Amino Acid Sequence; Amyloid; Circular Dichroism; Cysteine; De

2009
Identification of casein kinase-1 phosphorylation sites on TDP-43.
    Biochemical and biophysical research communications, 2009, May-01, Volume: 382, Issue:2

    Topics: Amino Acid Sequence; Amyotrophic Lateral Sclerosis; Brain; Casein Kinase I; Dementia; DNA-Binding Pr

2009
Frontotemporal dementia and parkinsonism with the P301S tau gene mutation in a Jewish family.
    Journal of neurology, 2003, Volume: 250, Issue:6

    Topics: Adult; Algeria; Cerebral Cortex; Dementia; DNA Mutational Analysis; Family Health; Female; Humans; I

2003
Another phenotype of frontotemporal dementia and parkinsonism linked to chromosome-17 (FTDP-17) with a missense mutation of S305N closely resembling Pick's disease.
    Journal of neurology, 2003, Volume: 250, Issue:8

    Topics: Asparagine; Chromosomes, Human, Pair 17; Dementia; Dentate Gyrus; Genetic Linkage; Humans; Immunohis

2003
Pick's disease pathology of a missense mutation of S305N of frontotemporal dementia and parkinsonism linked to chromosome 17: another phenotype of S305N.
    Dementia and geriatric cognitive disorders, 2004, Volume: 17, Issue:4

    Topics: Asparagine; Base Sequence; Brain; Dementia; DNA Mutational Analysis; Genetic Linkage; Heterozygote;

2004
Promotion of hyperphosphorylation by frontotemporal dementia tau mutations.
    The Journal of biological chemistry, 2004, Aug-13, Volume: 279, Issue:33

    Topics: Brain; Chromosomes, Human, Pair 17; Dementia; DNA; Electrophoresis, Polyacrylamide Gel; Humans; Immu

2004
Neuroserpin Portland (Ser52Arg) is trapped as an inactive intermediate that rapidly forms polymers: implications for the epilepsy seen in the dementia FENIB.
    European journal of biochemistry, 2004, Volume: 271, Issue:16

    Topics: Amino Acid Substitution; Arginine; Biopolymers; Catalysis; Circular Dichroism; Dementia; Epilepsy; H

2004
Characterization of a double (amyloid precursor protein-tau) transgenic: tau phosphorylation and aggregation.
    Neuroscience, 2005, Volume: 130, Issue:2

    Topics: Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Brain; Chromosomes, Human, Pair 17;

2005
Increased frequency of the LRRK2 G2019S mutation in an elderly Ashkenazi Jewish population is not associated with dementia.
    Neuroscience letters, 2006, Jul-10, Volume: 402, Issue:1-2

    Topics: Aged, 80 and over; Aging; Dementia; DNA Mutational Analysis; Female; Glycine; Humans; Jews; Leucine-

2006
Lrrk2 G2019S substitution in frontotemporal lobar degeneration with ubiquitin-immunoreactive neuronal inclusions.
    Acta neuropathologica, 2007, Volume: 113, Issue:5

    Topics: Aged; Amino Acid Substitution; Dementia; Female; Glycine; Humans; Inclusion Bodies; Leucine-Rich Rep

2007
The novel Tau mutation G335S: clinical, neuropathological and molecular characterization.
    Acta neuropathologica, 2007, Volume: 113, Issue:4

    Topics: Adult; Dementia; DNA Mutational Analysis; Glycine; Humans; Male; Microscopy, Electron, Transmission;

2007
The DeltaK280 mutation in MAP tau favors exon 10 skipping in vivo.
    Journal of neuropathology and experimental neurology, 2007, Volume: 66, Issue:1

    Topics: Alzheimer Disease; Blotting, Western; Brain; Dementia; Exons; Female; Humans; Immunohistochemistry;

2007
Screening for the LRRK2 G2019S and codon-1441 mutations in a pathological series of parkinsonian syndromes and frontotemporal lobar degeneration.
    Journal of the neurological sciences, 2008, Jul-15, Volume: 270, Issue:1-2

    Topics: Dementia; DNA Mutational Analysis; Female; Genetic Predisposition to Disease; Genetic Testing; Glyci

2008
TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: a genetic and histopathological analysis.
    The Lancet. Neurology, 2008, Volume: 7, Issue:5

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alanine; Amyotrophic Lateral Sclerosis; Brain; Child; De

2008
Identification of phosphorylation sites in PHF-TAU from patients with Guam amyotrophic lateral sclerosis/parkinsonism-dementia complex.
    Journal of neuropathology and experimental neurology, 1996, Volume: 55, Issue:10

    Topics: Aged; Amyotrophic Lateral Sclerosis; Binding Sites, Antibody; Blotting, Western; Brain Chemistry; De

1996
Familial dementia caused by polymerization of mutant neuroserpin.
    Nature, 1999, Sep-23, Volume: 401, Issue:6751

    Topics: Biopolymers; Cerebral Cortex; Dementia; Female; Humans; Inclusion Bodies; Male; Neuropeptides; Neuro

1999
Familial dementia caused by polymerization of mutant neuroserpin.
    Nature, 1999, Sep-23, Volume: 401, Issue:6751

    Topics: Biopolymers; Cerebral Cortex; Dementia; Female; Humans; Inclusion Bodies; Male; Neuropeptides; Neuro

1999
Familial dementia caused by polymerization of mutant neuroserpin.
    Nature, 1999, Sep-23, Volume: 401, Issue:6751

    Topics: Biopolymers; Cerebral Cortex; Dementia; Female; Humans; Inclusion Bodies; Male; Neuropeptides; Neuro

1999
Familial dementia caused by polymerization of mutant neuroserpin.
    Nature, 1999, Sep-23, Volume: 401, Issue:6751

    Topics: Biopolymers; Cerebral Cortex; Dementia; Female; Humans; Inclusion Bodies; Male; Neuropeptides; Neuro

1999
The FTDP-17-linked mutation R406W abolishes the interaction of phosphorylated tau with microtubules.
    Journal of neurochemistry, 2000, Volume: 74, Issue:6

    Topics: Amino Acid Sequence; Animals; Antibodies, Monoclonal; Antineoplastic Agents; Chromosomes, Human, Pai

2000
[The effective of L-threo-3,4-dihydroxyphenylserine (L-threo-DOPS) in hypersomnia and subcortical dementia caused by bilateral medial thalamic and midbrain infarcts].
    Rinsho shinkeigaku = Clinical neurology, 1988, Volume: 28, Issue:3

    Topics: Aged; Cerebral Infarction; Dementia; Disorders of Excessive Somnolence; Droxidopa; Female; Humans; M

1988